Results 161 to 170 of about 16,636 (201)
Efficacy and Safety of Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis in a China Cohort of a Double-Blind, Randomised, Phase 3 Trial (ReSTORE China). [PDF]
MycosesHuang H +6 more
europepmc +1 more source
CAMEO-a cross-sectional survey study on candidemia management in Germany. [PDF]
Med MycolReinhold I +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 2001
Caspofungin is the first in a new class of antifungal agents, the glucan synthesis inhibitors, that interfere with fungal cell wall synthesis. Caspofungin exhibited in vitro and in vivo efficacy against a wide range of fungi and yeasts including Aspergillus and Candida species.
G M, Keating, B, Jarvis
+6 more sources
Caspofungin is the first in a new class of antifungal agents, the glucan synthesis inhibitors, that interfere with fungal cell wall synthesis. Caspofungin exhibited in vitro and in vivo efficacy against a wide range of fungi and yeasts including Aspergillus and Candida species.
G M, Keating, B, Jarvis
+6 more sources
Drugs of Today, 2002
Available systemically effective antifungal agents for the treatment of invasive fungal infections are few. With the increasing recognition of a need for newer antifungal drugs, caspofungin has been introduced as the first member of a new class of compounds called echinocandins.
P H, Chandrasekar, E K, Manavathu
openaire +3 more sources
Available systemically effective antifungal agents for the treatment of invasive fungal infections are few. With the increasing recognition of a need for newer antifungal drugs, caspofungin has been introduced as the first member of a new class of compounds called echinocandins.
P H, Chandrasekar, E K, Manavathu
openaire +3 more sources
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
New England Journal of Medicine, 2002 Background: Caspofungin is an echinocandin agent with fungicidal activity against candida species. We performed a double-blind trial to compare caspofungin with amphotericin B deoxycholate for the primary treatment of invasive candidiasis.Methods: We ...
Coleman Rotstein +2 more
exaly +2 more sources
The pharmacology and clinical use of caspofungin
Expert Opinion on Drug Metabolism and Toxicology, 2007 Caspofungin was the first echinocandin to be licensed for the treatment of invasive fungal infections. Caspofungin has in vitro and in vivo activity against Candida spp.
William Hope, Shmuel Shoham
exaly +2 more sources